ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Ceva receives positive opinion from the European Medicines Agency (EMA) for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines

30 September 2021, at 9:06am

Ceva recently received a positive opinion from the CVMP, scientific Committee for Veterinary Medicinal Products for Circovac® + Hyogen® ready to Mix: DUO™, which now means swine producers across Europe can administer Circovac® and Hyogen® together, as DUO™, offering improved welfare and convenience at farm level.

DUO™, the combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age, covering the whole fattening period.

Coupled with the systematic use of the Ceva Lung Program, which measures lung lesions in the slaughterhouse, the combination product offers an unparalleled opportunity for producers to improve the respiratory health in their herds. A single global web platform: The Precision Health Program (PHP) combines these lung lesion scoring reports and provides real time reports to participating farms. This allows producers to benchmark their performance (within company and against the top national producers) and therefore take the most informed preventative, respiratory health decisions. The dynamic program, based on continual farm data analysis and audit, has been demonstrated to provide significant health improvements over time.

The newly available presentation of Hyogen® (100 dose) matches with the current Circovac® 100 dose presentation to allow for easy mixing of the 2 vaccines in one vial.